Perspektif mahasiswa farmasi universitas mataram terhadap vaksinasi COVID-19
DOI:
10.29303/sjp.v3i2.167Downloads
Abstract
COVID-19 is an infectious disease caused by SARS-CoV-2 with a high transmission rate. The Indonesian Ministry of Health made efforts to contain the spread of the virus by conducting a vaccination program. This study’s objective to examine the extent to which UNRAM Pharmacy students provide the opportunity to vaccinate, the known types of COVID-19 vaccines, and student responses to the outbreak of the emergence of a new variant, namely the COVID-19 Delta variant. The method used in this study was cross-sectional, with a sample of 163 active students of Pharmacy UNRAM. Sampling was done boldly by using google forms. The results of the study were 98% of respondents started to vaccinating against COVID-19. There are three types of vaccines known to students, namely Sinovac, Astra Zeneca, and Moderna.
Keywords:
COVID-19, Vaccines, ImmunityReferences
Chung, Y. H., Beiss, V., Fiering, S. N., & Steinmetz, N. F. (2020). Covid-19 vaccine frontrunners and their nanotechnology design. ACS Nano, 14(10), 12522–12537. https://doi.org/10.1021/acsnano.0c07197
Farina Gandriyani. (2020). Pelaksanaan Vaksinasi Covid-19 Di Indonesia ; Hak Atau Kewajiban Warga Negara. Rechts Vinding, 10(1).
Gennaro, F. (2020). Corona Virus Disease (COVID-19) Current Status and Future Perspective : Narative Review. International Journal Of Environmental Research and Public Health, 1(2).
Hartono, H., & Yusuf, Y. (2021). Tinjauan Molekuler dan Epidemiologi Mutasi pada Virus SARS-CoV-2. Bionature, 22(1), 43–49. https://doi.org/10.35580/bionature.v22i1.22379
Ismail, A. (2020). Gambaran Karakteristik Mahasiswa dan Alumni Farmasi Fkik Uin Alauddin Makassar : Sebuah Tinjauan Berbasis Gender. Sipakalebbi, 4(1), 275–288.
Jakarta, U. M., Dahlan, J. K. H. A., Tim, K. C., & Selatan, K. T. (2021). WEBINAR TALKID DENGAN TEMA “ GERAKAN MELAWAN COVID -19 ANTARA HARAPAN DAN.
Kemenkes. (2020). Petunjuk Teknisi Pelaksanaan Vaksinasi dalam Rangka Penanggulangan Pandemi Corona Virus Disease 2019. https://www.kemkes.go.id/article/view/20031700001/Dokumen-Resmi-dan-Protokol-Penanganan-COVID-19.html
Kementerian Kesehatan. (2020). Pedoman Pencegahan dan Pengendalian Corona Virus Disease-19. In Kementerian Kesehatan. Kementerian Kesehartan RI. https://doi.org/10.33654/math.v4i0.299
Kementerian Kesehatan RI. (2020). Vaksin Covid-19. Kemkes Berita Rilis.
Kementerian Kesehatan RI, UNICEF, & WHO. (2020). Survei penerimaan vaksin COVID-19 di Indonesia. November. https://www.unicef.org/indonesia/id/coronavirus/laporan/survei-penerimaan-vaksin-covid-19-di-indonesia
Kumar, U., Kumar, S., Varghese, S., Chamoli, R., & Barthwal, P. (2013). Review Article DNA VACCINE : A MODERN BIOTECHNOLOGICAL APPROACH TOWARDS HUMAN WELFARE AND CLINICAL TRIALS . International Journal of Research in Biomedicine and Biotechnology, 3(1), 17–20. http://urpjournals.com/tocjnls/28_13v3i1_4.pdf
Makmun, A., & Hazhiyah, S. F. (2020). Tinjauan Terkait Pengembangan Vaksin Covid 19. Molucca Medica, 13, 52–59. https://doi.org/10.30598/molmed.2020.v13.i2.52
Maria Deloria Knoll. (2021). Oxford–AstraZeneca COVID-19 vaccine efficacy. The Lancet, 397(10269), 72–74.
Purnamasari dan Raharyani. (2020). Tingkat Pengetahuan dan Perilaku Masyarakat Kabupaten Wonosobo Tentang COVID-19. Jurnal Imiah Kesehatan, 6(1).
Saifulmujani research and consulting. (2021). Hanya Sekitar 46% warga yang Bersedia Divaksinasi Covid-19. diakses pada 28 Juli 2021.
Satgas covid. (n.d.). Peta Sebaran. Retrieved July 21, 2021, from https://covid19.go.id/peta-sebaran
Tuwu, D. (2020). Kebijakan Pemerintah Dalam Penanganan Pandemi Covid-19. Journal Publicuho, 3(2), 267. https://doi.org/10.35817/jpu.v3i2.12535
Wan, Y., Shang, J., Sun, S., Tai, W., Chen, J., Geng, Q., He, L., Chen, Y., Wu, J., Shi, Z., Zhou, Y., Du, L., & Li, F. (2020). Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry. Journal of Virology, 94(5). https://doi.org/10.1128/jvi.02015-19
Wang F, Kream RM, S. G. (2020). An evidence based perspective on mRNA-SARS-CoV-2 vaccine development. : : International Medical Journal of Experimental and Clinical Research, 26(1), 121.
WHO. (2021). Rekomendasi interim untuk penggunaan vaksin COVID-19 Moderna mRNA-1273. 7, 1–8.
World Health Organization (WHO). (2013). Module 2 : types of vaccine and adverse reactions. WHO Vaccine Safety Basics, 38–60.
Yuliana. (2020). Yuliana. 2(February), 124–137. https://doi.org/10.2307/j.ctvzxxb18.12
License
Copyright (c) 2022 Nur Amalina Sabdarrifa, Baiq Bismiranti Haris, Zulfiana Fitrianingrum Annas, Candra Eka Puspitasari
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with Sasambo Journal of Pharmacy (SJP), agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Lisensi Creative Commons Atribusi 4.0 Internasional. This license allows authors to use all articles, data sets, graphics and appendices in data mining applications, search engines, web sites, blogs, and other platforms by providing an appropriate reference. The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Sasambo Journal of Pharmacy
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
